(Q34007868)

30 July 2017

title

Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial (English)

1 reference

30 July 2017

1 reference

Eirik Kjelby

1

1 reference

30 July 2017

Hugo A Jørgensen

2

1 reference

30 July 2017

Rune A Kroken

3

1 reference

30 July 2017

Else-Marie Løberg

4

1 reference

30 July 2017

Erik Johnsen

5

1 reference

30 July 2017

publication date

31 August 2011

1 reference

30 July 2017

1 reference

30 July 2017

volume

11

1 reference

30 July 2017

page(s)

145

1 reference

Impact of second-generation antipsychotics and perphenazine on depressive symptoms in a randomized trial of treatment for chronic schizophrenia

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178484

Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178484

Utility of atypical antipsychotics in the treatment of resistant unipolar depression

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178484

The impact of loss to follow-up on hypothesis tests of the treatment effect for several statistical methods in substance abuse clinical trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178484

Effectiveness of second generation antipsychotics: a systematic review of randomized trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178484

''R"--project for statistical computing

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178484

Methodological issues in current antipsychotic drug trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178484

A preclinical and clinical rationale for quetiapine in mood syndromes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178484

Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178484

Newer treatment studies for bipolar depression

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178484

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178484

Atypical antipsychotics in bipolar depression: potential mechanisms of action.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178484

Antipsychotic and antidepressive effects of second generation antipsychotics: two different pharmacological mechanisms?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178484

Practice guideline for the treatment of patients with schizophrenia, second edition.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178484

Quetiapine. A review of its use in the management of schizophrenia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178484

Validity of the depressive dimension extracted from principal component analysis of the PANSS in drug-free patients with schizophrenia.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178484

Diagnosis and treatment of mood disorders that co-occur with schizophrenia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178484

Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic agents

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178484

Treatment of schizoaffective disorder and schizophrenia with mood symptoms

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178484

Should we consider mood disturbance in schizophrenia as an important determinant of quality of life?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178484

The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178484

The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178484

Assessing substance use disorder in persons with severe mental illness

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178484

The positive and negative syndrome scale (PANSS) for schizophrenia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178484

The significance of depression in the prediction of relapse in chronic schizophrenia.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178484

Diagnosis of secondary depression in schizophrenia: implications for DSM-IV.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178484

Suicide and schizophrenia: a nationwide psychological autopsy study on age- and sex-specific clinical characteristics of 92 suicide victims with schizophrenia.

5 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-145

A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-145

Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-145

Depression in schizophrenia: comparison of first- and second-generation antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-145

Differential effect of quetiapine on depressive symptoms in patients with partially responsive schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-145

Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-145

Efficacy and tolerability of quetiapine in patients with schizophrenia switched from other antipsychotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-145

Efficacy and tolerability of quetiapine in patients with schizophrenia who switched from haloperidol, olanzapine or risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-145

Psychological sequelae of torture and organised violence suffered by refugees from Iraq. Trauma-related factors compared with social factors in exile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-145

Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic group comparisons.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178484

Mixed-Effects Models in Sand S-PLUS

29 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-145

Selection Bias in Clinical Trials With Antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-145

Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia I: sensitivity, reliability, and validity

21 January 2018

1 reference

12 December 2020

A depression rating scale for schizophrenics

1 reference

12 December 2020

Pyramidical model of schizophrenia

1 reference

12 December 2020

Adopting Nutrition Care Process Terminology at the National Level: The Norwegian Experience in Evaluating Compatibility with International Statistical Classification of Diseases and Related Health Problems, 10th Revision, and the Existing Norwegian

1 reference

12 December 2020

Dose equivalence of the antipsychotic drugs

1 reference

12 December 2020

Depression in chronic schizophrenia

1 reference

12 December 2020

Five factor model of schizophrenia: replication across samples

1 reference

12 December 2020

Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol

1 reference

12 December 2020

Depression in people with first-episode schizophrenia

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-244X-11-145

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference